U.S. FDA panel split over approval of Durect's non-opioid painkiller
January 16, 2020 at 14:38 PM EST
Independent experts on an FDA advisory panel on Thursday were split over the approval of Durect Corp's experimental non-opioid painkiller to manage post-surgical pain.